CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2018; 37(S 01): S1-S332
DOI: 10.1055/s-0038-1672419
E-Poster – Anatomy & Approaches
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Timing of Surgical Treatment for Idiopathic Normal Pressure Hydrocephalus: Association Between Treatment Delay and Reduced Short-term Benefit

Hugo Fialho
1   Johns Hopkins Hospital
,
Sharif Vakili
2   The Johns Hopkins University School of Medicine
,
Dane Moran
2   The Johns Hopkins University School of Medicine
,
Alice Hung
2   The Johns Hopkins University School of Medicine
,
Benjamin D. Elder
2   The Johns Hopkins University School of Medicine
,
Lee Jeon
2   The Johns Hopkins University School of Medicine
,
Eric W. Sankey
2   The Johns Hopkins University School of Medicine
,
Ignacio Jusué-Torres
2   The Johns Hopkins University School of Medicine
,
Rory C. Goodwin
2   The Johns Hopkins University School of Medicine
,
Jennifer Lu
2   The Johns Hopkins University School of Medicine
,
Jamie Robison
2   The Johns Hopkins University School of Medicine
,
Daniele Rigamonti
1   Johns Hopkins Hospital
› Author Affiliations
Further Information

Publication History

Publication Date:
06 September 2018 (online)

 
 

    Introduction: A growing body of evidence suggests that longer durations of preoperative symptoms may correlate with worse postoperative outcomes following cerebrospinal fluid (CSF) diversion for treatment of idiopathic normal pressure hydrocephalus (iNPH).

    Objective: The aim of this study is to determine whether the duration of preoperative symptoms alters postoperative outcomes in patients treated for iNPH.

    Methods: The authors conducted a retrospective review of 393 cases of iNPH involving patients treated with ventriculoperitoneal (VP) shunting. The duration of symptoms prior to the operative intervention was recorded. The following outcome variables were assessed at baseline, 6 months postoperatively, and at last follow-up: gait performance, urinary continence, and cognition.

    Results: The patients’ median age at shunt placement was 74 years. Increased symptom duration was significantly associated with worse gait outcomes (relative risk [RR] 1.055 per year of symptoms, p = 0.037), and an overall absence of improvement in any of the classic triad symptomology (RR 1.053 per year of symptoms, p = 0.033) at 6 months postoperatively. Additionally, there were trends toward significance for symptom duration increasing the risk of having no 6-month postoperative improvement in urinary incontinence (RR 1.049 per year of symptoms, p = 0.069) or cognitive symptoms (RR 1.051 per year of symptoms, p = 0.069). However, no statistically significant differences were noted in these outcomes at last follow-up (median 31 months). Age stratification by decade revealed that prolonging symptom duration was significantly associated with lower Mini-Mental Status Examination scores in patients aged 60–70 years, and lack of cognitive improvement in patients aged 70–80 years.

    Conclusions: Patients with iNPH with longer duration of preoperative symptoms may not receive the same short-term benefits of surgical intervention as patients with shorter duration of preoperative symptoms. However, with longer follow-up, the patients generally reached the same end point. Therefore, when managing patients with iNPH, it may take longer to see the benefits of CSF shunting when patients present with a longer duration of preoperative symptoms.


    #

    No conflict of interest has been declared by the author(s).